147 related articles for article (PubMed ID: 22916594)
1. [HIV in elderly].
Mück B; Trapana G; Jäger H
MMW Fortschr Med; 2012 May; 154 Suppl 1():26-8. PubMed ID: 22916594
[No Abstract] [Full Text] [Related]
2. [Metabolic syndrome and cardiovascular diseases in HIV patients].
Seybold U
MMW Fortschr Med; 2012 May; 154 Suppl 1():30-1. PubMed ID: 22916595
[No Abstract] [Full Text] [Related]
3. Metabolic Syndrome Among Antiretroviral Therapy-Naive Versus Experienced HIV-Infected Patients Without Preexisting Cardiometabolic Disorders in Western Kenya.
Osoti A; Temu TM; Kirui N; Ngetich EK; Kamano JH; Page S; Farquhar C; Bloomfield GS
AIDS Patient Care STDS; 2018 Jun; 32(6):215-222. PubMed ID: 29851503
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
Jantarapakde J; Phanuphak N; Chaturawit C; Pengnonyang S; Mathajittiphan P; Takamtha P; Dungjun N; Pinyakorn S; Pima W; Prasithsirikul W; Phanuphak P
AIDS Patient Care STDS; 2014 Jul; 28(7):331-40. PubMed ID: 24914459
[TBL] [Abstract][Full Text] [Related]
5. [Cardiovascular risk factors associated with antiretroviral therapy].
Pérez-Camacho I; Camacho A; Torre-Cisneros J; Rivero A
Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():24-32. PubMed ID: 20172412
[TBL] [Abstract][Full Text] [Related]
6. HIV Infection Is Associated With Type 2 Diabetes Mellitus.
Høgh J; Gelpi M; Hove-Skovsgaard M; Afzal S; Nordestgaard BG; Gerstoft J; Benfield T; Storgaard H; Nielsen SD
J Acquir Immune Defic Syndr; 2021 Dec; 88(4):e32-e35. PubMed ID: 34520442
[No Abstract] [Full Text] [Related]
7. Metabolic Syndrome in HIV-patients in Antiretroviral Therapy.
Vargas-Pacherrez D; Cotrim HP; Pires L; Cunha V; Coelho V; Brites C; Daltro C
Curr HIV Res; 2020; 18(6):388-395. PubMed ID: 32516101
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral therapy-associated diseases are common in the long-term.
Lanzafame M; Lattuada E; Zoppini G; Vento S
AIDS Res Hum Retroviruses; 2011 Sep; 27(9):931-2. PubMed ID: 21182461
[No Abstract] [Full Text] [Related]
9. [HIV infection: a chronic disease with new challenges].
Jung N; Fischer J; Lehmann C; Rockstroh JK; Fätkenheuer G
Dtsch Med Wochenschr; 2011 Aug; 136(31-32):1581-3. PubMed ID: 21809246
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of metabolic complications after 10 years of antiretroviral treatment in Senegal].
Diouf A; Cournil A;
Bull Soc Pathol Exot; 2014 Oct; 107(4):234-7. PubMed ID: 24683016
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk associated with HIV therapy.
Currier JS
J Acquir Immune Defic Syndr; 2002 Sep; 31 Suppl 1():S16-23; discussion S24-5. PubMed ID: 12218440
[No Abstract] [Full Text] [Related]
12. Pharmacologic consideration for the use of antiretroviral agents in the elderly.
Rhee MS; Greenblatt DJ
J Clin Pharmacol; 2008 Oct; 48(10):1212-25. PubMed ID: 18812611
[TBL] [Abstract][Full Text] [Related]
13. Complications of Treatment in Youth with HIV.
Eckard AR; Fowler SL; Haston JC; Dixon TC
Curr HIV/AIDS Rep; 2016 Aug; 13(4):226-33. PubMed ID: 27234970
[TBL] [Abstract][Full Text] [Related]
14. Effects of antiretroviral treatment and nadir CD4 count in progression to cardiovascular events and related comorbidities in a HIV Brazilian cohort: a multi-stage approach.
Oliveira RVC; Shimakura SE; Campos DP; Hökerberg YHM; Victoriano FP; Ribeiro S; Veloso VG; Grinsztejn B; Carvalho MS
AIDS Care; 2018 May; 30(5):551-559. PubMed ID: 29058481
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Syndrome Among People Living with HIV Receiving Medical Care in Southern United States: Prevalence and Risk Factors.
Sears S; Buendia JR; Odem S; Qobadi M; Wortley P; Mgbere O; Sanders J; Spencer EC; Barnes A
AIDS Behav; 2019 Nov; 23(11):2916-2925. PubMed ID: 30929149
[TBL] [Abstract][Full Text] [Related]
16. Targets of metabolic toxicity of HIV antiretroviral drugs: the multiple roads to lipodystrophy and metabolic syndrome.
Domingo P; Villarroya F
Curr Pharm Des; 2010 Oct; 16(30):3337-8. PubMed ID: 20687885
[No Abstract] [Full Text] [Related]
17. Independent predictors of metabolic syndrome in HIV-infected patients.
Alencastro PR; Fuchs SC; Wolff FH; Ikeda ML; Brandão AB; Barcellos NT
AIDS Patient Care STDS; 2011 Nov; 25(11):627-34. PubMed ID: 21936688
[TBL] [Abstract][Full Text] [Related]
18. [HIV infection 2007].
Potthoff A; Brockmeyer N;
Med Klin (Munich); 2007 Jul; 102(7):531-9. PubMed ID: 17634871
[TBL] [Abstract][Full Text] [Related]
19. Tolerability of HAART in patients treated during acute HIV infection.
Vlassi C; Corpolongo A; D'Offizi G; Scognamiglio P; Salvatori MF; Fezza R; Narciso P
J Acquir Immune Defic Syndr; 2010 Aug; 54(5):e11-2. PubMed ID: 20647820
[No Abstract] [Full Text] [Related]
20. Evolution of HIV disease in the third millennium: clinical and related economic issues.
Manfredi R
Int J Antimicrob Agents; 2002 Mar; 19(3):251-3. PubMed ID: 11932152
[No Abstract] [Full Text] [Related]
[Next] [New Search]
